1 study found for:    21952094 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Interferon beta-1b (Betaseron, BAY86-5046)

Indicates status has not been verified in more than two years